PCR assay optimization before manufacturing transfer creates a controlled baseline that another team can reproduce. The objective is not to claim that every parameter is globally optimal. It is to define a suitable configuration, understand its sensitive variables, and separate unresolved assay behavior from effects introduced during manufacturing.
Primer and probe concentrations
Concentrations influence signal, background, efficiency, competition, and reagent cost. Singleplex conditions may not transfer directly into multiplex reactions. Record stock specifications, purification, working concentrations, mixing calculations, and the data used to select the final balance.
Master mix and reaction chemistry
Enzyme, buffer, magnesium, additives, passive reference, and inhibitor tolerance shape performance. If the final manufacturing partner will use a different source or formulation, equivalence should not be assumed. Define which materials are fixed and which may be substituted only after assessment.
Thermal and optical settings
Document temperatures, hold times, cycle count, ramp assumptions where relevant, acquisition steps, dye channels, color compensation, baseline, and threshold approach. Instrument software defaults can vary and are part of the reproducibility problem when they remain unwritten.
Sample matrix and extraction
An assay optimized only with clean synthetic material may behave differently in the intended matrix or extraction eluate. Development should use representative materials appropriate to the project's stage and clearly state what has and has not been assessed.
Controls and interpretation
Positive, negative, extraction, and internal controls serve different purposes. Their materials, concentrations, expected behavior, and interpretation rules should be defined. A control that competes with a low-level target can alter the complete reaction and deserves deliberate design.
Lock a transfer baseline
Before producing an evaluation lot, issue a controlled baseline containing the selected formula, oligonucleotide specifications, protocol, instrument settings, vessel, seal, analysis method, acceptance criteria, and reference data. Future changes can then be evaluated against a known version rather than memory.